These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 27788728)

  • 41. Usefulness of abnormal heart rate recovery on exercise stress testing to predict high-risk findings on single-photon emission computed tomography myocardial perfusion imaging in men.
    Gera N; Taillon LA; Ward RP
    Am J Cardiol; 2009 Mar; 103(5):611-4. PubMed ID: 19231321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exercise-induced muscle vasodilatation and treadmill exercise test responses in individuals without overt heart disease.
    Nunes RA; Giampaoli V; de Freitas HF; da Costa Pereira A; Araújo F; Correia GF; Rondon MU; Negrão CE; Mansur AJ
    Cardiology; 2014; 127(1):38-44. PubMed ID: 24192918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic value of treadmill exercise testing in very elderly patients: heart rate recovery as a predictor of mortality in octogenarians.
    Yanagisawa S; Miki K; Yasuda N; Hirai T; Suzuki N; Tanaka T
    Europace; 2011 Jan; 13(1):114-20. PubMed ID: 21084358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heritability, linkage, and genetic associations of exercise treadmill test responses.
    Ingelsson E; Larson MG; Vasan RS; O'Donnell CJ; Yin X; Hirschhorn JN; Newton-Cheh C; Drake JA; Musone SL; Heard-Costa NL; Benjamin EJ; Levy D; Atwood LD; Wang TJ; Kathiresan S
    Circulation; 2007 Jun; 115(23):2917-24. PubMed ID: 17548724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CKD and nonalcoholic fatty liver disease.
    Targher G; Chonchol MB; Byrne CD
    Am J Kidney Dis; 2014 Oct; 64(4):638-52. PubMed ID: 25085644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Sugimoto K; Inui H; Fukusato T
    World J Gastroenterol; 2015 Apr; 21(13):3777-85. PubMed ID: 25852263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.
    Lê KA; Bortolotti M
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):477-82. PubMed ID: 18542010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of bariatric surgery on nonalcoholic fatty liver disease.
    de Freitas AC; Campos AC; Coelho JC
    Curr Opin Clin Nutr Metab Care; 2008 May; 11(3):267-74. PubMed ID: 18403923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Related factors for heart rate recovery after treadmill exercise testing in patients with nonalcoholic fatty liver disease].
    Zhang J; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):696-698. PubMed ID: 27788728
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.